Publications

Complete List of Publications

Books

Glaucoma Drainage Devices: Springer, Editors: Shibal Bhartiya, Monica Gandhi

Clinical Decision Making in Glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Colin Clement, Syril Dorairaj, George Kong, Oscar Albis

Clinical Decision Making in Glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Colin Clement, Syril Dorairaj, George Kong, Oscar Albis

ISGS Textbook of Glaucoma surgery. Jaypee Brothers Medical Publishers. Editors: Tarek Shaarawy, Tanuj Dada, Shibal Bhartiya 

Manual of glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Parul Icchpujani

Practical Perimetry: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Murali Ariga. Ronnie George, George V

Living with Glaucoma (e pub Kindle version). Parul Icchpujani, Shibal Bhartiya

Manual of Glaucoma Screening. Jaypee Brothers Medical Publishers (In press)Editors: Shibal Bhartiya,  Tarek Shaarawy

Dutta’s Textbook of Ophthalmology (under compilation) Editor in Chief: Shibal Bhartiya, Editors: Namrata Sharma, Rajiv Raman.

Clinical Handbook of Glaucoma. Editors: Shibal Bhartiya, Maneesh Singh, Arijit Mitra

Master Cases in Glaucoma, Volume 1, Editor: Shibal Bhartiya

Master Cases in Retina (Vol 1) Incessant Nature Science Publishers. Shibal Bhartiya 2024
Clinical Insights into Glaucoma Management. Incessant Nature Science Publishers. Shibal Bhartiya 2024
LMR Ophthalmology: Incessant Nature Science Publishers. Shibal Bhartiya 2024

Video presentations

  1. Complications of trabeculectomy. Tanuj Dada, Shibal Bhartiya, World Glaucoma Congress, Paris 2011.
  2. Sangharsh ek kitanu ke saath: Anita Panda, Shibal Bhartiya et al.67th All India Ophthalmic Society meeting, Jaipur, Feb 2009
  3. AGV in refractory Glaucomas: Surgical caveats. Anita Panda, Shibal Bhartiya et al. AIOS, Jaipur, Feb 2009
  4. Bleb excision and scleral patch graft for hypotony maculopathy. T.Dada, Shibal Bhartiya. DOS Annual Conference, Mar 2009
  5. Nucleus delivery techniques in manual small incision cataract surgery. Panda A,Kumar A ,Bansal R ,Hennig A , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007
  6. Management of anterior capsule rupture in traumatic cataract during phacoemulsification. Mohan S, Panda A, Kumar A , Bansal R , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007

Peer reviewed indexed publications

Dr. Shibal Bhartiya: Expert Glaucoma Specialist & Clinician-Scientist in Gurgaon, is a globally recognized authority in Glaucoma
and Neuro-Ophthalmology. 
With over 27 years of experience, she is one of the few specialists in India who seamlessly bridges the gap between high-volume clinical excellence and international medical research. She is a prolific author of 28 medical textbooks and has
published over 200 peer-reviewed (94 on Pubmed)

research papers in international journals
. Her leadership in the field is
further cemented as the
Executive
Editor of the Journal of Current Glaucoma Practice
and her role on the Associate Advisory Committee of the
International Society of Glaucoma Surgery (ISGS)
Her work can be accessed on Pubmed, Google
Scholar
, ResearchGate
and
ORCID.

 

  1. Bhartiya S, Aggarwal A, Dada R. Bridging Genomics and Practice: Rethinking Genetic Counseling in Glaucoma. J Curr Glaucoma Pract. 2025 Oct-Dec;19(4):155-157. doi: 10.5005/jp-journals-10078-1503. Epub 2025 Dec 15. PMID: 41523176; PMCID: PMC12780359.
  2. Lang MV, Vasu P, Dorairaj EA, Bhartiya S, Dorairaj SK. Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence. J Curr Glaucoma Pract. 2025 Oct-Dec;19(4):223-228. doi: 10.5005/jp-journals-10078-1501. Epub 2025 Dec 15. PMID: 41523168; PMCID: PMC12780357.
  3. Bhartiya S, Kong YXG, Ramesh PV, Alam MM, Ambawata M. Evaluating the ease of use and clinical applicability of the Melbourne Rapid Field for visual field testing: A real-world experience. Indian J Ophthalmol. 2026 Jan 1;74(1):117-122. doi: 10.4103/IJO.IJO_1461_25. Epub 2025 Dec 29. PMID: 41460140.
  4. Bhartiya S, Zhang X, Perera S. Minimally Invasive Glaucoma Surgeries, Health Economics, and the Moral Imperative of Equity in Glaucoma Care. J Curr Glaucoma Pract. 2025 Jul-Sep;19(3):103-106. doi: 10.5005/jp-journals-10078-1489. PMID: 41113786; PMCID: PMC12533714.
  5. Bhartiya S, Ichhpujani P, Kapoor S, Parmar UPS, Singh D, Kumar S. Weighted Quality of Life in Glaucoma Patients with Advanced Disease. J Curr Glaucoma Pract. 2025 Apr-Jun;19(2):85-89. doi: 10.5005/jp-journals-10078-1474. Epub 2025 Jul 31. PMID: 41113687; PMCID: PMC12532238.
  6. Bhartiya S, Dorairaj SK. GLP-1 Receptor Agonists, Allostatic Load, and Reframing the Glaucoma Paradigm. J Curr Glaucoma Pract. 2025 Jan-Mar;19(1):1-2. doi: 10.5005/jp-journals-10078-1471. Epub 2025 Mar 24. PMID: 40417146; PMCID: PMC12096885.
  7. Bhartiya S, Ichhpujani P, Wadhwani M. Current perspectives in tackling glaucoma blindness. Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S189-S196. doi: 10.4103/IJO.IJO_3280_23. Epub 2025 Feb 21. PMID: 39982079; PMCID: PMC12013325.
  8. The metabolic shift: Unraveling the potential of ketogenic diet in glaucoma. Bhartiya S. J Curr Glaucoma Pract. 2024 Apr-Jun;18(2):43-44. doi: 10.5005/jp-journals-10078-1435.
  9. Dada T, Mahalingam K, Bhartiya S. Reversing Aging and Improving Health Span in Glaucoma Patients: The Next Frontier? J Curr Glaucoma Pract. 2024 Jul-Sep;18(3):87-93. doi: 10.5005/jp-journals-10078-1451. Epub 2024 Oct 29. PMID: 39575133; PMCID: PMC11576344.
  10. Ocular morbidity profiles of out-of-school children in a North Indian urban slum. Bhartiya S, Wadhwani M, Ichhpujani P, Parmar UPS.Indian J Ophthalmol. 2024 Apr 16. doi: 10.4103/IJO.IJO_622_23. Online ahead of print.PMID: 38622857
  11. Glaucoma Drug Prescription Pattern in North India: Public vs Private Sector Hospitals. Bhartiya S, Ichhpujani P, Parmar UPS, Kapoor S, Kaundal S, Kumar S.J Curr Glaucoma Pract. 2024 Jan-Mar;18(1):16-22. doi: 10.5005/jp-journals-10078-1438.PMID: 38585162
  12. Is GATT the Answer? Bhartiya S, Aktas Z, Ichhpujani P.J Curr Glaucoma Pract. 2023 Oct-Dec;17(4):167-168. doi: 10.5005/jp-journals-10078-1425.PMID: 38269261
  13. Lifestyle Measures for Glaucoma Patients: An Objective Social Media Content Analysis. Chahal R, Jindal A, Parmar UPS, Singh RB, Bhartiya S, Ichhpujani P.J Curr Glaucoma Pract. 2023 Jul-Sep;17(3):141-148. doi: 10.5005/jp-journals-10078-1412.PMID: 37920374
  14. Can We Ever Win with a Suprachoroidal Implant? Au L, Bhartiya S.J Curr Glaucoma Pract. 2023 Apr-Jun;17(2):55-57. doi: 10.5005/jp-journals-10078-1410.PMID: 37485461
  15. New Gonioscopy Technique for Finding Schwalbe’s Line: The Ortiz Maneuver. Albis-Donado O, Ortiz-Arismendi GE, Bhartiya S.J Curr Glaucoma Pract. 2023 Jan-Mar;17(1):37-39. doi: 10.5005/jp-journals-10078-1399.PMID: 37228312
  16. Long-term effect of panretinal photocoagulation on optic nerve head parameters in diabetic retinopathy using Heidelberg retinal tomography III.Wadhwani M, Bhartiya S, Sharma A, Sharma A, Upadhyay AD, Dada T.Oman J Ophthalmol. 2022 Dec 12;16(1):6-11. doi: 10.4103/ojo.OJO_182_2018. eCollection 2023 Jan-Apr.PMID: 37007232
  17. Ocular and Systemic Factors Associated with Glaucoma. Dada T, Verma S, Gagrani M, Bhartiya S, Chauhan N, Satpute K, Sharma N.J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):179-191. doi: 10.5005/jp-journals-10078-1383.PMID: 36793269
  18. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. Bhartiya S.J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390.PMID: 36793265
  19. Bhartiya S. Glaucoma Screening: Is AI the Answer? J Curr Glaucoma Pract. 2022 May-Aug;16(2):71-73. doi: 10.5005/jp-journals-10078-1380. PMID: 36128081; PMCID: PMC9452706.
  20. Bhartiya S, Shaarawy T, Dada T. Editorial. J Curr Glaucoma Pract. 2015 May- Aug;9(2):vii. Epub 2013 Sep 6. PMID: 26997837; PMCID: PMC4750029.
  21. Bhartiya S, Shaarawy T, Dada T. Editorial. J Curr Glaucoma Pract. 2014 May-Aug;8(2):v. Epub 2014 Jun 12. PMID: 26997815; PMCID: PMC4741168.
  22. Bhartiya S. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390. PMID: 36793265; PMCID: PMC9905873.
  23. Bhartiya S. Current Glaucoma Practice: The Covid-19 Impact. J Curr Glaucoma Pract. 2020 Jan-Apr;14(1):1-2. doi: 10.5005/jp-journals-10078-1275. PMID:32581461; PMCID: PMC7302611.
  24. Dada T, Ramesh P, Sethi A, Bhartiya S. Ethics of Glaucoma Widgets. J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):77-80. doi: 10.5005/jp-journals-10078-1288. PMID: 33867754; PMCID: PMC8028034.
  25. Bhartiya S, Ichhpujani P. How to Choose a Mentor? J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):128-9. doi: 10.5005/jp-journals-10008-1150. Epub 2013 Sep 6. PMID: 26997796; PMCID: PMC4741151.
  26. Ichhpujani P, Bhartiya S, Sharma A. Premium IOLs in Glaucoma. J Curr Glaucoma Pract. 2013 May-Aug;7(2):54-7. doi: 10.5005/jp-journals-10008-1138. Epub 2013 May 9. PMID: 26997783; PMCID: PMC4741180.
  27. Bhartiya S. Patient Centricity and the Ethics of Glaucoma Care. J Curr Glaucoma Pract. 2020 May-Aug;14(2):68-71. doi: 10.5005/jp-journals-10078-1281. PMID: 33304063; PMCID: PMC7695931.
  28. Dada T, Mahalingam K, Bhartiya S. Minimally Invasive Glaucoma Surgery-to Remove or Preserve the Trabecular Meshwork: That is the Question? J Curr Glaucoma Pract. 2021 May-Aug;15(2):47-51. doi: 10.5005/jp-journals-10078-1299. PMID: 34720492; PMCID: PMC8543745.
  29. Bhartiya S, Ichhpujani P, Shaarawy T. Surgery on the Trabecular Meshwork: Histopathological Evidence. J Curr Glaucoma Pract. 2015 May-Aug;9(2):51-61. doi: 10.5005/jp-journals-10008-1184. Epub 2015 Sep 25. PMID: 26997835; PMCID: PMC4750027.
  30. Ichhpujani P, Dada T, Bhartiya S. Biodegradable Collagen Implants in Trabeculectomy. J Curr Glaucoma Pract. 2015 Jan-Apr;9(1):24-7. doi: 10.5005/jp-journals-10008-1179. Epub 2015 Jan 15. PMID: 26997829; PMCID: PMC4741144.
  31.  Jha B, Bhartiya S, Sharma R, Arora T, Dada T. Selective Laser Trabeculoplasty: An Overview. J Curr Glaucoma Pract. 2012 May-Aug;6(2):79-90.doi: 10.5005/jp-journals-10008-1111. Epub 2012 Aug 16. PMID: 28028351; PMCID: PMC5161772.
  32. Ichhpujani P, Kalra G, Kaur R, Bhartiya S. Evolution of Glaucoma Research: A Scientometric Review. J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):98-105. doi: 10.5005/jp-journals-10078-1286. PMID: 33867758; PMCID: PMC8028030.
  33. Dhingra D, Bhartiya S. Evaluating glaucoma surgeries in the MIGS context.Rom J Ophthalmol. 2020 Apr-Jun;64(2):85-95. PMID: 32685772; PMCID: PMC7339697.
  34. Current Glaucoma Practice: The Covid-19 Impact Bhartiya S. J Curr Glau Prac 10.5005/jp-journals-10078-1275 (Epub)
  35. 24-hour Intraocular pressure monitoring: the way ahead. Bhartiya S, Gangwani M, Kalra RB, Aggarwal A, Gagrani M, Sirish KN. Rom J Ophthalmol. 2019 Oct-Dec;63(4):315-320.
  36. Long term effect of panretinal photocoagulation on retinal nerve fiber layer parameters in patients with proliferative diabetic retinopathy. Wadhwani M, Bali S, Bhartiya S, Mahabir M, Upadhaya A, Dada T, Sharma A, Mishra SK. Oman J Ophthalmol. 2019 Oct 11;12(3):181-185.
  37. Diurnal Variation of IOP in Angle Closure Disease: Are We Doing Enough? Bhartiya S, Wadhwani M, Rai O, Patuel M, Dorairaj S, Sirish KN. Rom J Ophthalmol. 2019 Jul-Sep;63(3):208-216.
  38. Revisiting Results of Conventional Surgery: Trabeculectomy, Glaucoma Drainage Devices, and Deep Sclerectomy in the Era of MIGS. Bhartiya S, Dhingra D, Shaarawy T. J Curr Glaucoma Pract. 2019 May-Aug;13(2):45-49.
  39. A Novel Mathematical Model of Glaucoma Pathogenesis. Faiq MA, Sidhu T, Sofi RA, Singh HN, Qadri R, Dada R, Bhartiya S, Gagrani M, Dada T. J Curr Glaucoma Pract. 2019 Jan-Apr;13(1):3-8
  40. The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End? Bhartiya S, Shaarawy T. J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):99-101.
  41. Citius, Altius, Fortius: Agreement between Perkins and Dynamic Contour Tonometry (Pascal) and the Impact of Altitude. Albis-Donado O, Bhartiya S, Gil-Reyes M, Casale-Vargas G, Arreguin-Rebollar N, Kahook MY.J Curr Glaucoma Pract. 2018 Jan-Apr;12(1):40-44
  42. Bleb needling with subconjunctival ologen insertion using IOL cartridge. Dada T, Angmo D, Bhartiya S, Ramananda K.Oman J Ophthalmol. 2018 Jan-Apr;11(1):94-96.
  43. Assessment of Retinal Nerve Fiber Layer Changes by Cirrus High-definition Optical Coherence Tomography in Myopia.Singh D, K Mishra S, Agarwal E, Sharma R, Bhartiya S, Dada T.J Curr Glaucoma Pract. 2017 May-Aug;11(2):52-57.
  44. In Vivo Confocal Microscopic Characteristics of Crystalline Keratopathy in Patients with Sclerokeratitis.Gupta N, Ganger A, Bhartiya S, Verma M, Tandon R.Ocul Immunol Inflamm. 2017 Feb 22:1-6.
  45.  Evaluation of Physical Properties of Generic and Branded Travoprost Formulations. Wadhwani M, Mishra SK, Angmo D, Velpandian T, Sihota R, Kotnala A, Bhartiya S, Dada T. J Curr Glaucoma Pract. 2016 May-Aug;10(2):49-55.
  46. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2015 Sep-Dec;9(3)
  47.  Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2015 May-Aug;9(2)
  48.  Surgery on the Trabecular Meshwork: Histopathological Evidence.Bhartiya S, Ichhpujani P, Shaarawy T.J Curr Glaucoma Pract. 2015 May-Aug;9(2):51-61.
  49. Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements.Angmo D, Bhartiya S, Mishra SK, Sharma R, Poojari A, Dada T.Nepal J Ophthalmol. 2014 Jul;6(12):185-191.
  50.  Scanning laser polarimetry in glaucoma.Dada T, Sharma R, Angmo D, Sinha G, Bhartiya S, Mishra SK, Panda A, Sihota R.Indian J Ophthalmol. 2014 Nov;62(11):1045-1055..
  51. New perspectives on target intraocular pressure.Clement CI, Bhartiya S, Shaarawy T.Surv Ophthalmol. 2014 Nov-Dec;59(6):615-26.
  52. Novel occurrence of axenfeld: Rieger syndrome in a patient with blepharophimosis ptosis epicanthus inversus syndrome.Shah BM, Dada T, Panda A, Tanwar M, Bhartiya S, Dada R. Indian J Ophthalmol. 2014 Mar;62(3):358-60.
  53. Novel occurrence of axenfeld: Rieger syndrome in a patient with blepharophimosis ptosis epicanthus inversus syndrome.Shah BM, Dada T, Panda A, Tanwar M, Bhartiya S, Dada R. Indian J Ophthalmol. 2014 Mar;62(3):358-65
  54. Complementary and Alternate Management of Glaucoma: The Verdict so Far Shibal Bhartiya, Parul Ichhpujani. Journal of Current Glaucoma Practice. Journal of Current Glaucoma Practice. Amy – Aug 2014; 54-57
  55. How to Choose a Mentor? Shibal Bhartiya, Parul Ichhpujani. Journal of Current Glaucoma Practice. Journal of Current Glaucoma Practice. Sept-Dec 2013; 128-129
  56. Editorial.Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2014 Jan-Apr;8(1):v.
  57. Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2014 May-Aug;8(2):v
  58. Editorial.Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2015 Jan-Apr;9(1):vii
  59. Editorial. Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2015 May-Aug;9(2):vii.
  60. Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):vii
  61. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2013 May-Aug;7(2):vii.
  62. Editorial. Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2013 Jan-Apr;7(1):v.
  63. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2012 Sep-Dec;6(3):v
  64. Cataract Surgery in Eyes with Previous Glaucoma Surgery: Pearls and Pitfalls Tanuj Dada, Shibal Bhartiya, Nafees Begum Baig. Journal of Current Glaucoma Practice. Sept-Dec 2013; 99-105
  65. Evaluation of the Van Herick Technique for Screening for Occludable Angles in an African Population Shibal Bhartiya, Tarek Shaarawy. Journal of Current Glaucoma Practice. May- Aug 2013; 88-90
  66. Premium IOLs in Glaucoma Parul Ichhpujani, Shibal Bhartiya, Anuj Sharma Journal of Current Glaucoma Practice. May- Aug 2013; 54-57
  67. Role of Lens Extraction in Primary Angle Closure Disease. Anubha Rathi, Reetika Sharma, Bhaskar Jha, Shibal Bhartiya, Anita Panda. Journal of Current Glaucoma Practice :January-April 2011, 20-25
  68. Evolution of keratoplasty: from darkness to light.Bhartiya S, Gupta N.J Indian Med Assoc. 2012 Oct;110(10):732-5.
  69. Test retest variability of TonoPen AVIA. Bhartiya S, Bali SJ, James M, Panda A, Dada T.Indian J Ophthalmol. 2013 Mar;61(3):129-31.
  70. Agreement of corneal thickness measurement using slitlamp and ultrasound pachymetry.Agarwal T, Bhartiya S, Dada T, Panda A, Jhanji V, Yu M.Eye Contact Lens. 2012 Jul;38(4):231-3.
  71. Comparative evaluation of Diaton and Goldmann applanation tonometers. Bali SJ, Bhartiya S, Sobti A, Dada T, Panda A. Ophthalmologica. 2012;228(1):42-6. doi: 10.1159/000336047. Ultrasound biomicroscopy in glaucoma.Dada T, Gadia R, Sharma A, Ichhpujani P, Bali SJ, Bhartiya S, Panda A.Surv Ophthalmol. 2011 Sep-Oct;56(5):433-50.
  72. Comparative evaluation of TonoPen AVIA, Goldmann applanation tonometry and non-contact tonometry. Bhartiya S, Bali SJ, Sharma R, Chaturvedi N, Dada T. Int Ophthalmol. 2011 Aug;31(4):297-302.
  73.  Ultrasound biomicroscopic assessment of angle parameters in patients with primary angle closure glaucoma undergoing phacoemulsification.Dada T, Mohan S, Bali SJ, Bhartiya S, Sobti A, Panda A.Eur J Ophthalmol. 2011 Sep-Oct;21(5):559-65.
  74.  Surgical management of glaucoma: evolving paradigms.Sharaawy T, Bhartiya S. Indian J Ophthalmol. 2011 Jan;59 Suppl:S123-30.
  75. Selective Laser Trabeculoplasty: An Overview Jha B, Shibal Bhartiya, Kumar R, Dada T. Journal of Current Glaucoma Practice. 2012; 6: 79-90
  76. Knowledge, Attitudes and Self-care Practices associated with Glaucoma among Hospital Personnel in a Tertiary Care Center in North India. Ichhpujani P, Shibal Bhartiya , Kataria M, Topiwala P. J Current Glau Prac 2012;6:108-112.
  77. The Need to maintain Intraocular Pressure over 24 HoursShibal Bhartiya , Ichhpujani P. J Current Glau Prac 2012;6:120-123.
  78. Patient Communication and the Glaucoma Surgeon. Shibal Bhartiya , Ichhpujani P. J Current Glau Prac 2011;5:1-7.
  79. Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas.Dada T, Bhartiya S, Vanathi M, Panda A. Indian J Ophthalmol. 2010 Sep-Oct;58(5):440-2.
  80.  Fibrin glue in ophthalmology.Panda A, Kumar S, Kumar A, Bansal R, Bhartiya S.Indian J Ophthalmol. 2009 Sep-Oct;57(5):371-9.
  81. Measurement of horizontal deviation in dissociated vertical deviation with a +6-diopter lens occluder.Dadeya S, Kamlesh, Naniwal SK, Fatima S. J Pediatr Ophthalmol Strabismus. 2003 Mar-Apr;40(2):115-6.
  82. Comeoscleral perforation after pterygium excision and intraoperative mitomycin C.Dadeya S, Fatima S.Ophthalmic Surg Lasers Imaging. 2003 Mar-Apr;34(2):146-8.
  83. Preliminary results of intraoperative daunorubicin in strabismus surgery. Dadeya S, Kamlesh, Fatima S. J Pediatr Ophthalmol Strabismus. 2002 Nov-Dec;39(6):340-4.
  84. Intraoperative daunorubicin versus conjunctival autograft in primary pterygium surgery.Dadeya S, Kamlesh, Khurana C, Fatima S.Cornea. 2002 Nov;21(8):766-9
  85. Primary inferior oblique overaction-management by inferior oblique recession. Kamlesh, Dadeya S, Kohli V, Fatima S. Indian J Ophthalmol. 2002 Jun;50(2):97-101.
  86.  A modified hang-back recession technique for horizontal strabismus.Dadeya S, Kamlesh, Fatima S, Bhola R, Joon MK.J Pediatr Ophthalmol Strabismus. 2002 Jul-Aug;39(4):195.
  87. The effect of anisometropia on binocular visual function. Dadeya S, Kamlesh, Shibal F.Indian J Ophthalmol. 2001 Dec;49(4):261-3.
  88. Effect of religious fasting on intra-ocular pressure.Dadeya S, Kamlesh, Shibal F, Khurana C, Khanna A. Eye (Lond). 2002 Jul;16(4):463-5.

Peer reviewed articles

  1. Theatre as a Modality for Socioemotional Learning in Children from Urban Slums: A Case Report from Gurgaon, India. Shibal Bhartiya, RV Gopala Krishna, Emily Dorairaj, IJAIMS- International Journal of Advanced and Integrated Medical Sciences. Sept_DEC 2024 Vol.9 No.3
  2. The Future of Ophthalmology Pedagogy: Embracing Innovation and Artificial Intelligence
    Shibal Bhartiya, P V Ramesh. OCULAR RESEARCH JOURNAL. JUL_DEC_ 2024 Vol.1 No.2
  3. Bhartiya, S., & Singh, T. (2023). A cross-sectional study assessing the effectiveness of hygiene related interventions and education delivered in an afterschool club in urban slums of Gurugram. International Journal Of Community Medicine And Public Health, 10(3), 1172–1177. https://doi.org/10.18203/2394-6040.ijcmph20230635
  4. Efficacy of rinse and treat protocol and its acceptability in patients with dry eye disease. Petteri Ingalsuo, Marju Koski, Anssi Poussu, Shibal Bhartiya, Arijit Mitra, Maneesh Singh, Shailley Jain, Monica Gandhi. Clin Exp Vis Eye Research Vol.6 No.2, Jul- Dec 2023
  5. Pink eye: A rose by any other name. Clin Exp Vis Eye Research Vol.6 No.1, Jan- Jun 2023
  6. Systemic Medications and Glaucoma, Medications that increase the risk of Glaucoma. Shibal Bhartiya Clin Exp Vis Eye Research Vol.5 No.2, Jul- Dec 2022
  7. The Ophthalmologists’ Headache. Shibal Bhartiya Clin Exp Vis Eye Research Vol.5 No.2, Jul- Dec 2022
  8. The Art of Clinical Practice in Ophthalmology. Shibal Bhartiya Oc Res J Jul-Dec 2024 Vol.1 No.1
  9. The Open-access Journal Controversy. Shibal Bhartiya Clin Exp Vis Eye Research Vol. 1, No. 1, Jan-June’ 2018
  10. The COVID-19 Black Swan Shibal Bhartiya Clin Exp Vis Eye Research Vol. 2, No. 1, Jan-June’ 2019
  11. Water drinking test: The second innings scorecard. Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol. 3, No. 1, July-Dec’ 2020
  12. Is it time for Precision Medicine in Glaucoma? Shibal Bhartiya, Deepika Dhingra, Parul Ichhpujani. Clin Exp Vis Eye Research Vol. 3, No. 1, July-Dec’ 2020
  13. Notes from ground zero. Shibal Bhartiya. Clin Exp Vis Eye Research Vol.4 No.1, Jan- Jun 2021
  14. Habitual driving vision in a large urban cohort in Western
    India – factors associated with non-adherence to Indian guidelines. Dr. Shibal Bhartiya, Nishant Kumar, Deepika Dhingra, Meenakshi Wadhwani. Clin Exp Vis Eye Research Vol.4 No.1, Jan- Jun 2021
  15. Online teaching and surgical simulators: Substitute for physical ophthalmology clinical and surgical training. Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol.4 No.2, Jul- Dec 2021
  16. Pilocarpine: The Renaissance Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol.5 No.1, Jul- Dec 2022
  17. Acceptability of a second lockdown in Western India: anniversary of lockdown one Shibal Bhartiya, Nishant Kumar 2630-2636; 2021-05-25
  18. Knowledge, attitude and practice pattern regarding use of masks, in an urban slum in West India Shibal Bhartiya, Nishant Kumar, Meenakshi Wadhwani 303-309; 2021-12-27
  19. Domestic violence and COVID-19: the twin pandemic Shibal Bhartiya, Nishant Kumar 2796-2798; 2021-05-25
  20. Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India Shibal Bhartiya, Nishant Kumar, Tarundeep Singh, Sathiabalan Murugan, Saranya Rajavel, Meenakshi Wadhwani 1170-1176; 2021-02-24
  21. Antibodies to SARS-CoV2 detectable for less than 50 days in polymerase chain reaction confirmed COVID-19 patients Nishant Kumar, Shibal Bhartiya, Tarundeep Singh 3378-3379; 2020-08-28
  22. Knowledge and attitudes regarding effect of diabetes mellitus on eyes and community-based screening for diabetes, hypertension, and visual impairment in central India- a community-based cross-sectional study Shibal Bhartiya, Tarundeep Singh, Nishant Kumar, Tarundeep Singh, Saranya Rajavel, Sathiabalan Murugan 4580-4587; 2022-11-28
  23. Knowledge, attitudes and practices regarding COVID-19 appropriate behaviour and willingness for vaccination among frontline police personnel in Mumbai, India Shibal Bhartiya, Babasaheb V. Tandale, Shailesh D. Pawar, Meenakshi Wadhwani, Nishant Kumar 2129-2136, 2022-04-27
  24. The COVID 19 Black Swan. Clin Exp Vision Eye Res 15713/ins.clever.38 Jun 2020
  25. Talk to you patient, Doc! Spaeth G, Ichhpujani P, Shibal Bhartiya. Glaucoma Today, BMC Today, March-April 2013; 14-17.
  26. http://bmctoday.net/glaucomatoday/2013/04/article.asp?f=talk-to-your-patient-doc
  27. Practical Tips: IOP assessment with the water drinking test. Clement CI, Shibal Bhartiya. Glaucoma Now – Issue No 1, 2013.
  28. http://glaucomanow.com/media/17315/glaucomanow_issue1_2013_practicaltips.pdf
  29. Treatment of Ocular Hypertension. Shibal Bhartiya, Clement CI. Australian Optometry Pharma, March 2013, 14-15.
  30. http://www.optometrists.asn.au/media/239059/pharma_magazine_-_low-res_for_web.pdf
  31. ICLs: Is it a safe bet? S Chaudhary, Shibal Bhartiya et al.  DOS Times, March 2012
  32. Femtosecond laser cataract surgery: The future is here. S Chaudhary, A Tara, Shibal Bhartiya. DOS Times, Jan 2012
  33. European Ophthalmic Review: Recent advances in the treatment of glaucoma: the need to maintain intra ocular pressure over 24 hours. Shibal Bhartiya, Tarek Shaarawy. 2011
  34.  International Glaucoma Review 12-3, December 2010.Transscleral diode laser cycloablation in patients with good vision by: Keith Barton, Shibal Bhartiya, Fabian Lerner, Paul Palmberg, Tarek Shaarawy, Kuldev Singh, Ravi Thomas
  35. Clinical Evaluation of Optic Nerve Head in Glaucoma Shibal Bhartiya, Ritu Gadia, Harinder Sethi, Anita Panda. Journal of Current Glaucoma Practice, September–December 2010; 4(3): 115-132
  36. Ocular surface squamous neoplasia. Noopur Gupta, Shibal Bhartiya. et al.Kerala Journ of Ophthalmology.Vol XXII. Issue 2, June 2010.
  37. http://ksos.in/ksosjournal/journalsub/Journal_Article_20_328.pdf
  38. Vascular Factors in Glaucoma  Dhawan M, Shibal Bhartiya, Mohan S. Journal of Current Glaucoma Practice, January–April 2010; 4(1): 29-35
  39. The Lens and Angle Closure Kumar G, Ichhpujani P, Shibal Bhartiya, Panda A, Journal of Current Glaucoma Practice, January–April 2010; 4(1): 13-20
  40. Pars Plana Ahmed Glaucoma Valve Implantation Journal of Current Glaucoma Practice, September–December 2009.Vol 3. No 3.35-40 Shibal Bhartiya ,Anita Panda
  41. Steroid induced Glacoma.Kerala Journal of Ophthalmology.Vol XXI,Issue 4, Dec 2009. Tanuj Dada, Soman Nair, Munish Dhawan, Shibal Bhartiya
  42. http://ksos.in/ksosjournal/journalsub/Journal_Article_18_281.pdf
  43. Relative Afferent Pupillary Defect. Sumita Sethi, Mridula Mehta, Shibal Bhartiya, Sonia Bhargav. DOS Times
  44. Phacomorphic glaucoma. Tanuj Dada, Shibal Bhartiya, Mahesh Kumar H.M., Anita Panda. DOS Times.
  45. Phacomorphic Glaucoma: Evolving Management Strategies. Journal of Current Glaucoma Practice, June –August 2008 Shibal Bhartiya ,Tanuj Dada, Harinder S Sethi, Anand Aggarwal, Vivek Dave
  46. Cataract and Coexistent Glaucoma: A Therapeutic Dilemma Journal of Current Glaucoma Practice, September-December 2008;2(3):33-47 Shibal Bhartiya ,Tanuj Dada, Harinder S Sethi, Anand Aggarwal, Vivek Dave
  47. History of IOL surgery .Shibal Bhartiya, Sumita Sethi et al .Delhi Jour of Ophthalmology.July-Aug.2009
  48. History of penetrating keratoplasty. Shibal Bhartiya, Anita P. Delhi Jour of Ophthalmology.Sept-Oct.2009
  49. Tonopen: A critical appraisal. Shibal Bhartiya, Sonia Bhargav, Sumita Sethi.DOS Times.Vol.14,No7.Jan,2009
  50. Target IOP: Tear sheet, DOS Times.Vol.14,No 8.Feb 2009 Shibal Bhartiya
  51. Ocular tuberculosis: current paradigms in diagnosis and management. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology Vol 14,no 7.Mar 2008
  52. Diabetic retinopathy: newer horizons. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol 14,no 7.Mar 2008
  53. Voriconazole: new hope for fungal infections. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8,July 2008
  54. Hyperbaric oxygen therapy. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8,July 2008
  55. Standardized nomenclature for uveitis. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8July 2008
  56. Repair of corneal perforations. Shalini M, Aggrawal A, Panda A, Shibal Bhartiya. DOS Times, Vol  14-No.2, Aug 2008
  57. Management of posterior capsular rupture: A vitreoretinal perspective. Rajpal Insaan, Shibal Bhartiya, Venkatesh P. Delhi Journal of Ophthalmology, Vol.15, No 8, July 2008
  58. Journal Abstracts. Thirumalesh, Shibal Bhartiya, Depankur Mahajan. Delhi Journal of Ophthalmology, Vol.15, No 8, July 2008
  59. Delhi: A Travel through time. Shibal Bhartiya, Subhash Dadeya, Strabismic Panorama 2008.
  60. Journal abstracts. Archna Gupta, Shibal Bhartiya, Subhash Dadeya Souvenir, Strabismic Panorama 2008.
  61. Collagen cross linkage: Newer vistas in ophthalmology.Indian Jour Refractive surgery.A Panda,S Mohan, Shibal Bhartiya .2007,Mar-Apr, 19-22.
  62. Journal Abstracts, Delhi Journal of Ophthalmology. Rajpal I, Shibal Bhartiya. Vol.13, no6. 2007
  63. Management of Amblyopia. Shibal Fatima, Das GK .Orissa State Jour of Ophthalmol.2005, 28-29.
  64. Screening for Retinopathy of Prematurity. Das GK, Shibal Fatima. Orissa State Journal of Opthalmolgy.2005, 17-19.
  65. Amblyopia Major Review. Kamlesh, Dedeya S, Shibal Fatima. Indian Journal of Strabismology and Pediatric Ophthalmology. 2001, 1:5-20.
  66. Comparative evaluation of intraoperative daunorubicin and mitomycin-C in strabismus surgery. Dadeya S, Kamlesh, Shibal Fatima, Joon MK, Khurana C. Indian Journal of Strabismology and Pediatric Ophthalmology. 2001, 1:5-20.
  67. A study to evaluate the changes in refractive and corneal status following horizontal muscle surgery. Kamlesh, Dedeya S, Shibal Fatima, Jain S. Indian Journal of Strabismology and Pediatric Ophthalmolgy 2001, 1:25-30.

Abstracts published

    1. Diurnal intraocular pressure fluctuatuations in eyes with glaucoma. Shibal Bhartiya, Icchpujani P. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    2. Knowledge, Attitude And Self-care Practice About Glaucoma In Personnel At Tertiary Healthcare Units. Ichhpujani P, Shibal Bhartiya, Sharma A. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    3. Diurnal intraocular pressure fluctuatuations in eyes with glaucoma. Shibal Bhartiya, Icchpujani P., Singh TD. Asia ARVO, Nov 2013, New Delhi, India
    4. Getting The Eye Drop In Correctly: Child’s Play?? Sharma A, Ichhpujani P, Shibal Bhartiya. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    5. Safety and efficacy of trans-scleral diode laser cyclophotocoagulation (TS- DLCP) in indian eyes with poor vision. Singh K, Shibal Bhartiya. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    6. Needle Revision of Failed Blebs with Subconjunctival Bevacizumab and 5-Fluorouracil Injection: A Comparative Case Series. Ichhpujani P, Shibal Bhartiya. APGC 2012, Bali
    7. Continuous IOP monitoring in patients with glaucoma and ocular hypertension treated with Tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. European Glaucoma Societ Meeting 2012, Copenhagen
    8. Ease of administration of antiglaucoma medication: monodose versus multidose vials. Shibal Bhartiya, Shaarawy T. World Glaucoma Congress, 2011, Paris
    9. ASOCT Evaluation of the Deep Scleral Trench Technique of Ahmed Glaucoma Valve Implantation. Shaarawy T, Shibal Bhartiya. World Glaucoma Congress, 2011, Paris
    10. Continuous IOP monitoring in glaucoma patients treated with tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. World Glaucoma Congress, 2011, Paris
    11. Evaluation of IOP measurements using Tonopen Avia in central and peripheral part of cornea. S Majumdar, A Sobti, Shibal Bhartiya et al. Asia ARVO, Singapore, January 2011.
    12. Effect of change in posture in intraocular pressure using Tonopen  Avia  Amit Sobti,Saptorshi Majumdar, Raashi Arora, Shibal Bhartiya, Anita Panda and Tanuj Dada . Asia ARVO, Singapore, January 2011
    13. Evaluation of IOP measurements using Tonopen Avia in central and peripheral part of cornea. S Majumdar, A Sobti, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    14. Effect of posture on IOP using Tonopen Avia. A Sobti, S Majumdar, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    15. Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Retinal Nerve Fiber Layer Thickness Measurements. A Sobti, S Majumdar, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    16. With a little help from my friends: Shibal Bhartiya, T Shaarawy.5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    17. Surgery for the Jedi: Shibal Bhartiya, N V Ricart. T Shaarawy.5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    18. Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Retinal Nerve Fiber Layer Thickness Measurements. Shibal Bhartiya, M. Kumar, V. Kumar, S. Khanduja, S.K. Mishra, T. Dada. ARVO,Florida, USA 2010
    19. Prevalence of Plateau Iris in Indian Eyes With Primary Angle Closure Glaucoma. G. Kumar, A. Sharma, A. Panda, Shibal Bhartiya, I. Bhatiya, T. Dada. ARVO, Florida, USA 2010.
    20. Corneal Topography Changes After Goldmann Applanation Tonometry. Tushar Agarwal, Shibal Bhartiya, Tanuj Dada, Murugesan Vanathi, Anita Panda .World Cornea Congress, Boston, USA,2010
    21. Hunter’s syndrome and Buphthalmos in a girl : An unusual ophthalmic association Sethi S, Shibal Bhartiya, Mehta M, Chandra M, Ghose S. Congress of European Association for Vision and Eye Research,2009,Slovenia.
    22. Effect of Two Different Macular Birefringence Imaging Protocols Used for Corneal Compensation, on Retinal Nerve Fiber Layer Thickness Parameters Using Scanning Laser Polarimetry With Variable Corneal Compensation (GdxVCC) in Normals and Eyes Having Macular Lesions .V. Dave, T. Dada, A. Aggarwal, J. Ashar, Shibal Bhartiya, A. Panda.ARVO,2009 Florida
    23. Test retest variability of the Tono-pen Avia.T Dada, Shibal Bhartiya, M James, A Panda et al ARVO,2009 Florida,USA
    24. Test retest variability of the cirrus OCT. Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA
    25. Comparitive evaluation of Cirrus and Stratus OCT in evaluation of retinal nerve fibre layer thickness. Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA
    26. Intraocular pressure elevation associated with use of nasal steroids. P. Srilathaa, T Dada. Shibal Bhartiya
    27. Pars Plana AGV implantation Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA.
    28. Test retest variability of the Tono-pen Avia.T Dada, Shibal Bhartiya,M James ,A Panda et al World Glaucoma Congress, 2009 Boston, USA
    29. Effect of Two Different Macular Birefringence Imaging Protocols Used for Corneal Compensation, on Retinal Nerve Fiber Layer Thickness Parameters Using Scanning Laser Polarimetry With Variable Corneal Compensation (GdxVCC) in Normals and Eyes Having Macular Lesions .V. Dave, T. Dada, A. Aggarwal, J. Ashar, Shibal Bhartiya, World Glaucoma Congress, 2009 Boston, USA
    30. Harry Potter and the Ophthalmologists nemesis. Shibal Bhartiya, S Khokhar, International congress of Glaucoma surgery, 2009, Geneva
    31. Harry Potter and the Ophthalmologists Nemesis . Shibal Bhartiya, S Khokhar Asia ARVO Meeting, Hyderabad ,Jan 2009
    32. Test retest variability of the Tono-pen Avia. M James, Shibal Bhartiya, T Dada Asia ARVO Meeting, Hyderabad , Jan 2009
    33. Effect of topical anaesthetic agent on corneal thickness in myopia. Shibal Bhartiya, A Panda et al. 67th All India Ophthalmic Society Meeting , Jaipur, Feb 2009
    34. Demographic profile of epibulbar dermoids in a tertiary care centre, A Panda, S Mohan, A Aggarwal, M Vanathi, Shibal Bhartiya. 66th All India Ophthalmic Society meeting , Bangalore, Feb 2008
    35. Evaluation of angle chamber parameters after cataract extraction in chronic primary angle closure glaucoma .Dada T, A Panda, S Mohan, A Aggarwal, Shibal Bhartiya. 66th All India Ophthalmic Society meeting , Bangalore , Feb 2008
    36. Kamlesh’s technique for inferior oblique recession. Kamlesh, Dedeya S, Shibal Fatima: Clinical and Experimental Ophthalmology. 2002; 445.Presented at the International Congress of ophthalmology,2002 , Sydney
    37. Corneal topographic changes after pterygium surgery. Shibal Fatima, Dadeya S, Kamlesh. Clinical and Experimental Ophthalmology.2002; 246. Presented at the International Congress of ophthalmology, 2002 , Sydney
    38. Changes in refractive status following strabismus surgery. Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    39. Comparative evaluation of intraoperative daunorubicin and mitomycin-C in strabismus surgery. Dadeya S, Kamlesh, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    40. Levo-dopa as an adjuvant to conventional occlusion in amblyopia. Kamlesh, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    41. Modified hang back muscle recession for exotropia. Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 146. Presented at the International Congress of ophthalmology,2002 , Sydney
    42. Knapp’s procedure versus inferior rectus recession in DEP-II, Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental Ophthalmolgy.2002, 445. Presented at the International Congress of ophthalmology,2002 ,Sydney
    43. ARVO 2014, Orlando, Florida. “Intraocular pressure (IOP) related pattern in patients with primary angle closure (PAC) and primary angle closure glaucoma (PACG) before and after laser peripheral iridotomy (LPI).”Shibal Bhartiya, Rene Gookeop, Sonya S Zoula.
    44. ARVO 2014, Orlando, Florida. “Citius, Altius, Fortius: agreement between Perkins and Dynamic Contour Tonometry (Pascal) and the impact of altitude” Oscar A Donado, Shibal Bhartiya et al.

Chapters in books

  1. Criteria for surgical success. Shibal Bhartiya, Ivan Goldberg. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  2. Intraocular Pressure Reduction Conundrum: Surgery or Drugs? Shibal Bhartiya, Monica Gandhi, Colin Clement, Parul Ichhpujani, Tarek M Shaarawy. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  3. Newer glaucoma surgical procedures: How and when to choose. Shibal Bhartiya, Parul Ichhpujani ISGS Textbook of Glaucoma Surgery. Shibal Bhartiya, Parul Ichhpujani. Jaypee Brothers Medical Publishers, 2014
  4. Releasable sutures in trabeculectomy. Parul Ichhpujani, Shibal Bhartiya. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  5. Diode laser cyclophotocoagulation. Shibal Bhartiya, Parul Ichhpujani , Dewang Angmo. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  6. Postoperative management of non-penetrating glaucoma surgeries. Glaucoma. Elsevier 2013
  7. Non-penetrating glaucoma surgeries: mechanism of action. Glaucoma. Elsevier 2013
  8. Spotlight: If primary deep sclerectomy fails. Glaucoma. Elsevier 2013
  9. Crystalens: Surgical Technique. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  10. ICL Explantation. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  11. Femtosecond cataract surgery: The surgical technique. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  12. IOL power calculations. . Postgraduate Ophthalmology, Jaypee brothers, 2011
  13. Corneal Hysteresis. Postgraduate Ophthalmology, Jaypee brothers, 2011
  14. Femtosecond lasers in Ophthalmology. Postgraduate Ophthalmology, Jaypee brothers, 2011
  15. Mastering Phacoemulsification in Difficult Situations, Jaypee Brothers Medical Publishers, 2008, Pg253-67
  16. Phacoemulsification in Hyperopia. Mastering Phacoemulsification In Difficult Situations, Jaypee Brothers Medical Publishers, 2008, Pg100-05
  17. New Investigations in Glaucoma. Instant Clinical Diagnosis In Ophthalmology: Glaucoma.. Pg210-249. Jaypee Brothers Medical Publishers,2008
  18. Lasers In Glaucoma. Instant Clinical Diagnosis In Ophthalmology: Glaucoma. Pg 250-267.Jaypee Brothers Medical Publishers,2008
  19. Evolution of Keratoplasty. Jaypee Brothers Medical Publishers,2008
  20. Diode Laser Cyclophotocoagulation: Video Assisted Skill Transfer, Jaypee Brothers Medical Publishers,2008
  21. Phacomorphic Glaucoma: Evolving Management Strategies Jaypee Brothers Medical Publishers,2009
  22. AGV With Phacoemulsification, Jaypee Brothers Medical Publishers,2009
  23. Phacoemulsification With Trabeculectomy: Single Site, Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009.
  24. Phacoemulsification With Trabeculectomy:Two Site, Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009
  25. Combined cataract and AGV surgery. Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009
  26. Pars Plana AGV Implantation: Surgical Technique, Jaypee Brothers Medical Publishers,2009
  27. MICS With Trabeculectomy, Jaypee Brothers Medical Publishers,2009
  28. Under publication: Pitfalls in the diagnosis of closed-angle glaucoma. Shibal Bhartiya, Parul Ichhpujani, Monica Gandhi, Oscar Albis Donado. Ed: H V Nema. Jaypee Brothers Medical Publishers.

Oral presentations, original research

  1. Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost Shibal Bhartiya, Aref A, Shaarawy T. APAO, 2012, Hyderabad, India
  2. Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. APGC 2012, Bali.
  3. Continuous IOP monitoring in glaucoma patients treated with tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. World Ophthalmology Congress, Abu Dhabi Feb. 2012
  4. SLT In POAG Patients Of Indian Subcontinent Origin. Shibal Bhartiya, T Shaarawy.5th Internatonal congress of Glaucoma Surgery, New Delhi, November 2010
  5. Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. Amit Sobti, Shibal Bhartiya, Mahesh HM Kumar, Ajay Sharma, Sunil K. Mishra, Tanuj Dada.16th  Indian eye Research group Meeting, Hyderabad, Aug 2010.
  6. Evaluation of the Tono-pen Avia and its Comparison with Goldman Applanation and Non Contact tonometers . Shibal Bhartiya, T Dada, M. James, G. Behera, R. Sihota, A. Panda. Asia ARVO Meeting, Hyderabad ,Jan 2009
  7. Fibrin glue: freedom from the vagaries of sutures. S Khokhar, Shibal Bhartiya et al.67th AIOS, Jaipur , Feb 2009
  8. Comparitive evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. Shibal Bhartiya, Jayaprakash V, T Dada, A Panda.DOS Annual Conference,March 2009.
  9. Tear meniscometry. M Jain, T Dada, Shibal Bhartiya et al.  DOS Annual Conference,March 2009
  10. Dengue:A foe for ophthalmologists Abhiyan K , Shibal Bhartiya, Subrata M et al . 66th All India Ophthalmic Society meeting , Bangalore, Feb, 2008
  11. To evaluate the epidemiology, microbiological profile and surgical outcome in childhood infective keratitis .A Aggarwal, A Panda, Shalini Mohan, M Vanathi, Shibal Bhartiya, R Bansal . 66th All India Ophthalmic Society meeting ,Feb, Bangalore, 2008
  12. OSSN: current paradigms in diagnosis and management. Shibal Bhartiya, Anita Panda. DOS annual conf ,pan ophthalmology live, Mar 2008 ,Delhi
  13. Prevention of IOL extrusion during triple procedure by iris bridge suture. Shibal Bhartiya, R Bansal, P Soni, A Panda  . 66th All India Ophthalmic Society meeting , Bangalore 2008
  14. Levodopa as an adjuvant to conventional occlusion for treatment of amblyopia in children. Kamlesh, Shibal Bhartiya, R Bhola, S Goel, G Goyal. American Academy of Ophthalmology, Nov 2008
  15. Clear corneal tunnel infections following phacomulsification. Shibal Bhartiya, Panda A. Madan Mohan Cornea Society Meeting, April 2007, New Delhi.
  16. Role of antibiotics in irrigating fluids during cataract surgery. Khurana C, Kamlesh, Shibal Bhartiya, Joon MK, Dadeya S. All India Ophthalmological Society meeting, Delhi, Jan, 2003.
  17. A randomized trial comparing intraoperative MMC and daunorubicin after Pterygium excision. Khurana C, Kamlesh, Shibal Bhartiya, Joon MK, Dadeya S.First Seri ARVO Meeting, Singapore, Feb, 2003.
  18. Clear lens extraction and intraocular lens implantation in anisometropic amblyopia. Kamlesh, Dadeya S, Shibal Bhartiya. All India Ophthamological Society meeting, Ahmedabad, Jan, 2002.
  19. A modified non-adjustable hang back muscle recession technique. Kamlesh, Bhola R, Shibal Bhartiya, Dadeya S. All India Ophthalmological Society meeting, Ahmedabad, Jan 2002.
  20. Evaluation of levo-dopa as a therapeutic adjunct to  conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal Bhartiya. DOS Midcon, 2001

Video presentations

  1. Complications of trabeculectomy. Tanuj Dada, Shibal Bhartiya, World Glaucoma Congress, Paris 2011.
  2. Sangharsh ek kitanu ke saath: Anita Panda, Shibal Bhartiya et al.67th All India Ophthalmic Society meeting, Jaipur, Feb 2009
  3. AGV in refractory Glaucomas: Surgical caveats. Anita Panda, Shibal Bhartiya et al. AIOS, Jaipur, Feb 2009
  4. Bleb excision and scleral patch graft for hypotony maculopathy. Dada, Shibal Bhartiya. DOS Annual Conference, Mar 2009
  5. Nucleus delivery techniques in manual small incision cataract surgery. Panda A,Kumar A ,Bansal R ,Hennig A , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007
  6. Management of anterior capsule rupture in traumatic cataract during phacoemulsification. Mohan S, Panda A, Kumar A , Bansal R , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress.
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparitive evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements.S.Bhartiya, Jayaprakash V, T Dada, A Panda.DOS Annual Conference,March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to  conventional occlusion in  amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013

Invited Faculty for training programs

  1. New Technology for IOP monitoring. Symposium: Glaucoma. Asia ARVO, New Delhi, November, 2013
  2. Optic Disc Documentation. Symposium: Optic Nerve and Glaucoma. Asia ARVO, New Delhi, November, 2013
  3. Late complications of drainage implants. Symposium: Tubes. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
  4. Complications of SLT and ALT treatment. Symposium: Laser Trabeculoplasty for open angle glaucoma. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
  5. Guest lecture” If glaucoma is a 24 hour disease, why don’t we consider the 24 hour IOP in the risk management of our glaucoma patients as a routine. Glaucons 2012, Glaucoma society of India Meeting, Coimbatore, India, October 2012.
  6. Guest lecture: “New developments in glaucoma surgery.” WOC, Abu Dhabi, UAE, 2012
  7. Chairperson: “ New therapeutic approach in glaucoma” WOC, Abu Dhabi, UAE, 2012
  8. Trabeculoplasty Revolutionising glaucoma management. ESCRS, 2011, Vienna Austria.
  9. Antifibrotics: Instruction course on Emerging Glaucoma surgery. World Glaucoma Congress, June-July 2011, Paris, France
  10. Non penetrating surgery: tips and pearls: World Glaucoma Congress, June-July 2011, Paris, France
  11. Diurnal Intraocular Pressure Monitoring: Whats new? SOE/AAO meeting, Geneva, Switzerland, June 2011
  12. Guest Lecture: “I will get SLT”. If I had glaucoma Meeting . Geneva, Switzerland. 27 January 2011.
  13. Guest Lecture: “Glaucoma”. Swiss Eye Week, Biel, Switzerland. 21-26 January 2011
  14. Guest Lecture: “Aqueous humor dynamics”. Swiss Eye Week, Biel, Switzerland. 21-26 January 2011
  15. Guest Lecture: SLT: A developing country perspective. 7th Aswan Ophthalmic meeting, Aswan, Egypt. January 2011.
  16. Coordinator: ICGS Film Festival, 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  17. Guest lecture: SLT: The First drop. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  18. Instruction Course: Gonioscopy. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  19. Instruction Course: Anterior Segment Imaging. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  20. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) Oct, 2010; Beirut, Lebanon. Trabeculectomy versus non-penetrating procedures: The debate goes on..
  21. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) October, 2010; Beirut, Lebanon. Glaucoma drainage devices: Indications, technical pearls & complications
  22. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) October, 2010; Beirut, Lebanon. New glaucoma surgical procedures that do not rely on the conjunctiva
  23. Guest lecture: Management of Phacomorphic Glaucoma, Russian Glaucoma Society Meeting, December 2009
  24. Judge and moderator: Free paper presentation in cataract and glaucoma, South Asian Association of Ophthalmology, 22-24 Aug,2008

Non Domain Knowledge Publications

Types of Glaucoma: Open Angle, Closed Angle, Normal Tension, and More

Types of Glaucoma: Open Angle, Closed Angle, Normal Tension, and More, explained by Dr Shibal Bhartiya, glaucoma specialist in Gurgaon.

Glaucoma is not a single disease. It is a family of conditions, each with different causes, risk factors, and treatment approaches. What they share is a common outcome: damage to the optic nerve, leading to progressive and irreversible vision loss if untreated.

Understanding which type of glaucoma you have helps you ask better questions and follow your treatment plan with more confidence. This page explains the main types, from the most common to the less well known, written for patients rather than clinicians.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Not all glaucomas behave the same way, and the treatment that is right for open-angle glaucoma may be wrong for angle-closure or normal tension glaucoma. Getting the diagnosis right, and the type right, is where good glaucoma care begins.

If you are uncertain about your diagnosis, a structured second opinion can bring clarity.

THE TWO MAIN TYPES OF GLAUCOMA

Q1. What is the difference between open-angle and closed-angle glaucoma?

Most glaucomas fall into one of two broad categories, determined by the anatomy of the drainage angle of the eye.

Open-angle glaucoma is by far the more common type of glaucoma. The drainage angle is open and appears normal, but fluid drains too slowly, causing pressure to build gradually over months and years. It has no symptoms in the early stages. Patients typically lose peripheral vision first, and the brain compensates so well that many people do not notice the loss until the disease is advanced. This is why regular screening is essential, particularly for those with risk factors.

Closed-angle glaucoma occurs when the drainage angle is narrow or blocked, preventing fluid from draining. It can occur suddenly (acute angle closure) or gradually (chronic angle closure). The acute form is a medical emergency with symptoms including severe eye pain, redness, blurred vision, and nausea. The chronic form is subtler and may mimic open-angle glaucoma.

Note: The distinction between the two types of glaucoma (open and closed angle) is made using a test called gonioscopy. This single test shapes all subsequent treatment decisions.

CLOSED-ANGLE GLAUCOMA

Q2. I have been diagnosed with angle-closure glaucoma. What does that mean for me?

In angle-closure glaucoma, the iris (the coloured part of the eye) is too close to the drainage angle, narrowing or blocking it. When the angle closes, fluid cannot drain and eye pressure rises sharply.

The acute form causes a sudden, severe rise in pressure. Symptoms include a red, painful eye with blurred vision, coloured halos around lights, headache, and nausea. This is an eye emergency; seek immediate medical help if this happens.

The chronic form builds more slowly, with few symptoms other than occasional coloured halos and mild headaches. It can go undetected for years without a formal eye examination.

Treatment for angle-closure glaucoma starts with a laser procedure called laser peripheral iridotomy (LPI). This creates a small opening in the iris to provide an alternative drainage pathway. After LPI, some patients require no further treatment; others need long-term eye drops. Your doctor will monitor your pressure and angle anatomy over time.

Note: Family members of patients with angle-closure glaucoma have a higher risk of the same condition. Preventive laser iridotomy can be offered to at-risk relatives before any acute episode occurs.

NORMAL TENSION GLAUCOMA

Q3. My doctor says I have glaucoma, but my eye pressures are normal. How is that possible?

This is understandably confusing. Between 10 and 25 percent of people with glaucoma have eye pressures that fall within the normal range (below 21 mmHg). This is called normal tension glaucoma (NTG), or low tension glaucoma.

The exact cause is not fully understood. Two leading theories are that the optic nerve is unusually sensitive to pressure and sustains damage even at pressures that would be harmless in most people, or that the blood supply to the optic nerve is compromised, making it vulnerable to damage independent of pressure. Of all the types of glaucoma, this is perhaps the most confusing for patients.

Conditions associated with normal tension glaucoma include:

  • Japanese ancestry (NTG is significantly more common in East Asian populations)
  • A family history of normal tension glaucoma
  • Migraines and vasospastic disorders such as Raynaud’s disease
  • Sleep apnoea
  • Alzheimer’s disease

Treatment still focuses on lowering eye pressure, like all other types of glaucoma. Even when eye pressure is within the normal range to start with, clinical trials have shown this slows progression. Eye drops, laser, or surgery may be used depending on the rate of progression and individual risk factors.

Note: Normal tension glaucoma often progresses more slowly than high-pressure glaucoma, but regular monitoring is still essential. Missing follow-up appointments is the most common reason for avoidable vision loss.

OCULAR HYPERTENSION

Q4. My eye pressures are high but my doctor says I do not have glaucoma. What is ocular hypertension?

If your eye pressure is above the normal range but your optic nerve and visual field show no signs of damage, you have ocular hypertension (OHT). It is not glaucoma, but it is a significant risk factor for developing glaucoma.

Not everyone with high eye pressure will develop glaucoma. Your individual risk depends on your age, ethnicity, family history, and corneal thickness (thicker corneas can give falsely high pressure readings).

Your doctor will weigh your risk profile before deciding whether to treat. Options include eye drops or selective laser trabeculoplasty (SLT). In lower-risk patients, careful monitoring without treatment is often appropriate, since all glaucoma medications carry some side effect burden.

Whether or not you receive treatment, regular eye checks are essential. The goal is to detect any optic nerve or visual field changes before significant vision is lost. Knowing your risk early is one of the best things you can do for your vision.

GLAUCOMA SUSPECT

Q5. My doctor says I am a glaucoma suspect. My tests were normal. Why do I still need annual monitoring?

A glaucoma suspect is someone whose optic nerve appearance raises concern, even when eye pressure and visual field tests are currently normal.

The most common reason is a larger than average cup-to-disc ratio (the proportion of the optic nerve head occupied by the central cup). A ratio above 0.5, or a difference of 20 percent or more between the two eyes, warrants closer monitoring. Other reasons include borderline eye pressures or a strong family history of glaucoma.

This does not mean you have glaucoma. It means your doctor wants a baseline record to compare against over time. If the optic nerve or visual field changes, that change can be detected early and treatment started before significant vision is lost.

Most glaucoma suspects are asked to return for annual or biannual testing. Once several years of stable results have been recorded, the interval between visits may be extended.

Note: The value of being labelled a glaucoma suspect is that it keeps you in the system. Early detection is the single most powerful tool for preventing glaucoma blindness.

SECONDARY GLAUCOMA

Q6. What is secondary glaucoma, and what causes it?

Secondary glaucoma is glaucoma caused by another identifiable condition or event, rather than arising on its own. It is managed in the same way as primary glaucoma (eye drops, laser, or surgery), but the underlying cause must also be addressed.

The most common secondary types of glaucoma include:

  • Pseudoexfoliation glaucoma: A protein-like material deposits on the lens and drainage structures of the eye, blocking outflow. This is one of the most common secondary glaucomas in India and tends to cause higher pressures and faster progression than primary open-angle glaucoma. It requires close monitoring and often more aggressive treatment.
  • Pigmentary glaucoma: Pigment granules shed from the back of the iris clog the drainage angle. It typically affects younger, myopic (short-sighted) patients and is often missed because these patients are not in the standard high-risk age group for glaucoma screening.
  • Steroid-induced glaucoma: Long-term use of steroid eye drops, nasal sprays, skin creams, or oral steroids can raise eye pressure in susceptible individuals. If you are on any form of steroid medication for any condition, ask your doctor whether your eye pressure has been checked.
  • Traumatic glaucoma: An injury to the eye can damage the drainage angle and cause pressure to rise, sometimes years after the original injury. Any history of significant eye trauma should be disclosed to your eye doctor.
  • Neovascular glaucoma: New, abnormal blood vessels grow over the drainage angle, blocking outflow. It is most commonly associated with poorly controlled diabetes and retinal vein occlusion. It is one of the more difficult types to manage and often requires surgery.

Note: If you have a systemic condition such as diabetes, or are on long-term steroid medication, make sure your eye doctor is aware. These are glaucoma risk factors that are often overlooked.

CONGENITAL AND CHILDHOOD GLAUCOMA

Q7. My child has been diagnosed with glaucoma. How is that possible, and what should I expect?

Glaucoma can affect any age group, though it is most common in adults over 40. In children, the most common cause is a structural defect in the drainage angle that is present from birth; this is called congenital glaucoma or primary infantile glaucoma.

Signs that parents typically notice first include:

  • Cloudy or hazy eyes
  • Unusual sensitivity to light; the child may turn away from bright light or bury their face
  • Excessive tearing
  • Eyes that appear larger than normal (because raised pressure causes the infant eye to expand)

Eye drops may be started initially to control pressure, but surgery is almost always required for congenital glaucoma. Early surgical intervention gives the best chance of preserving good vision throughout the child’s life.

Some children also have a co-existing cataract or other eye abnormality that needs to be managed alongside the glaucoma. Glasses, patching therapy for amblyopia (lazy eye), and follow-up surgeries may all be part of the long-term plan.

Children with glaucoma can lead fully independent lives. Even where some vision has been lost, tailored rehabilitation and visual aids allow children to participate in all age-appropriate activities. As a parent, remaining engaged with the care team and encouraging the child’s independence are the most important things you can do.

Note: Congenital glaucoma is rare. If your child has been diagnosed, seek care from a specialist with specific paediatric glaucoma experience. Early and consistent follow-up is critical.

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
+91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.

Glaucoma FAQs: Expert Answers from a Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.

These answers are drawn from real questions patients bring to the clinic: at first diagnosis, during follow-up, and when seeking a structured glaucoma second opinion in Gurgaon. If you do not find what you are looking for here, reach out directly.


What is glaucoma? Can it be prevented?

Glaucoma is a group of eye diseases that damage the optic nerve, causing progressive and irreversible vision loss. It is the second most common cause of blindness worldwide. Most people have no symptoms until significant damage has already occurred.

Glaucoma cannot be prevented. However, early detection and consistent treatment can slow progression and protect functional vision for life. The key is finding it before the damage is done. This is why regular screening matters, especially if you carry a family history of glaucoma.

Glaucoma tests are painless. A standard screening includes a vision check and eye pressure measurement. Depending on your risk profile, your doctor may also recommend a visual field test, an OCT scan to measure nerve fibre thickness, and a gonioscopy to examine the drainage angle of the eye. Learn more about glaucoma diagnosis in Gurgaon.


What puts me at risk for glaucoma?

Anyone above 40 should have an annual eye check. The following risk factors increase urgency significantly:

  • Family history of glaucoma — the single strongest risk factor
  • History of eye injury or trauma
  • Long-term use of steroid medications, including eye drops, inhalers, or oral steroids
  • Diabetes or thyroid disease
  • History of migraines or vasospastic disorders such as Raynaud’s disease
  • Sleep apnea
  • Alzheimer’s disease
  • High myopia (shortsightedness) or high hypermetropia (longsightedness)
  • Symptoms such as frequent prescription changes, coloured haloes around lights, headaches with nausea, or sudden blurring of vision

Vision lost to glaucoma cannot be recovered. Once nerve fibres are gone, they do not grow back. Regular eye exams are not optional if you carry these risk factors, they are what stand between you and preventable blindness. Understand glaucoma risk in depth here.


What happens during a glaucoma check-up?

Bring all previous eye records, your current glasses, any eye drops you are using, and your full medical file: not just eye records. Conditions such as diabetes, blood pressure, and thyroid disease all have relevance to glaucoma management.

Before you see the doctor, an optometrist will check your vision and eye pressure. Your doctor will then examine your optic nerve and retina. Additional tests may include a visual field test, an OCT scan, pachymetry (corneal thickness), a water drinking test, and a dilated eye exam.

After the tests, your doctor will explain findings clearly and outline a plan. Do not drive yourself to the appointment: your eyes may be dilated, which blurs vision for approximately three hours. Bring sunglasses.


I have glaucoma. Will I go blind?

In most cases, no- provided care is consistent. With proper medical care, glaucoma blindness is avoidable. Patients who use their eye drops as prescribed, attend follow-up appointments, and respond to treatment adjustments generally retain their vision for life.

The variables that matter most are: how early the disease was detected, how well eye pressure is controlled, and how reliably treatment is continued. Glaucoma is not a condition where you treat it and forget it. It requires steady, long-term management.

If glaucoma has advanced significantly, surgery may be recommended to slow further progression. In cases with severe visual field constriction, low vision aids can support daily mobility and independence.

The most important thing you can do today is ask your doctor honest questions about your disease stage and what your realistic prognosis looks like with good adherence. Lifestyle changes that support glaucoma management are discussed here.


How often should I see my doctor after a glaucoma diagnosis?

Frequency depends on disease severity, eye pressure control, and how stable your condition is. Here is a general framework:

  • Glaucoma suspect: Annual review with full testing, more often if your doctor recommends it
  • Early glaucoma, well-controlled: Every 6 to 12 months
  • Moderate or advanced glaucoma, or poorly controlled pressure: Every 3 to 6 months
  • After surgery: Intensive early follow-up, then gradual spacing as the eye stabilises

Even after surgery, eye drops may still be needed. Even if pressure is well-controlled, regular visits remain essential. Glaucoma can change silently. Gaps in follow-up are where damage accumulates.

If you are unsure whether your current follow-up schedule is appropriate, a structured glaucoma second opinion can provide clarity on both disease status and the right monitoring plan. Read more about glaucoma treatment planning here.


How can I support a family member or partner who has glaucoma?

A glaucoma diagnosis can be frightening. The word carries the weight of possible blindness, even when the actual prognosis with treatment is good. Your most important role early on is reassurance: with consistent care, blindness is not the inevitable outcome.

Practically, you can help by:

  • Reminding them to use their eye drops at the same time each day
  • Driving them to clinic appointments, particularly when eyes are dilated
  • Helping them track and attend follow-up visits
  • Learning enough about the condition to ask informed questions during consultations
  • Help them manage anxiety and depression through support, and medical help when required

If your family member has significant visual impairment, discuss visual rehabilitation options and low vision aids with their doctor. Support groups and rehabilitation services exist specifically for this. You do not have to navigate it alone. Read more about glaucoma and quality of life here.


What does vision loss from glaucoma actually feel like?

This is one of the most important, and most misunderstood, aspects of glaucoma. Most patients feel nothing. Even significant visual field loss often goes unnoticed because the brain compensates automatically by filling in missing areas. This is why patients sometimes underestimate their own disease severity.

The Glaucoma SIM App, developed in partnership with MSD Pharmaceuticals, the International Glaucoma Association, and Moorfields Eye Hospital, allows you to simulate what progressive glaucoma field loss looks like over time. It is available on the Apple App Store (search: Glaucoma SIM). Verify availability for your region before downloading.

Understanding what is happening to your vision, even when you cannot feel it, is one of the strongest motivators for staying consistent with treatment.


How do I choose a glaucoma doctor? When should I seek a second opinion?

A good glaucoma specialist listens carefully, explains your diagnosis in plain language, and makes treatment decisions transparently. Credentials matter: look for fellowship training in glaucoma, peer-reviewed publications, and clinical experience with complex cases including surgery.

A second opinion is not a sign of distrust. It is a standard part of managing a serious, lifelong condition. Seek one proactively if:

  • You have been recently diagnosed and want to confirm the findings
  • Your disease appears to be progressing despite treatment
  • Surgery has been recommended and you want to understand all your options
  • You are uncertain about your current treatment plan or follow-up schedule
  • You have seen multiple doctors and received different advice

Dr Shibal Bhartiya offers structured glaucoma second opinions in Gurgaon, as well as online consultations for patients elsewhere in India. She works in partnership with your local doctor to guide care over time- you do not need to change your primary treating physician. Submit a second opinion request here.


What are reliable resources for learning more about glaucoma?

Use these trusted sources for current, evidence-based information:


Book a Glaucoma Evaluation or Second Opinion

Not sure about your diagnosis? Concerned about progression? Want clarity before agreeing to surgery? Dr Shibal Bhartiya brings over 25 years of fellowship-trained glaucoma expertise, Mayo Clinic research collaboration, and 90+ peer-reviewed publications to every patient evaluation.

Consultations are available in person at Marengo Asia Hospitals, Sector 56, Gurgaon, and online for patients outside the city. Book an appointment here or call +91 88826 38735. You can also submit a second opinion request online.

For patients who live elsewhere, Dr Bhartiya is happy to work in partnership with your local eye doctor to guide and support your care over time.


Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.